Arzerra
29/10/2009
FDA Approves Ofatumumab (Arzerra) for Patients With CLL Refractory to Fludarabine and Alemtuzumab
ACTEMRA (Tocilizumab) approved in Switzerland for use in Rheumatoid Arthritis
18/12/2008
RoActemra Receives Positive Opinion in Europe for the Treatment of Rheumatoid ArthritisFirst-in-class therapy represents a novel approach to treat patients with moderate to severe rheumatoid arthritis.
Cladribine injectable Lipomed available by Unipharma
05/12/2008
LITAK® is approved for recurrent or refractory follicular and diffuse non-Hodgkin's lymphoma, recurrent or refractory chronic lymphocytic leukemia and recurrent or refractory lymphoplasmacytic lymphoma (Waldenström's macroglobulinemia) in Switzerland (country of origin) since 2000.
Ãœbernahme von Pharmion durch Celgene
17/11/2008
Unipharma wurde bestätigt, als Exklusiv-Distributor für Italien von Vidaza und Thalidomid Pharmion.
Bayer’s Novel Anticoagulant Xarelto® now also Approved in the EU
02/11/2008
Bayer will start marketing the new oral, once-daily anticoagulant very soon / First-in-class product to demonstrate superior efficacy to current standard of care
PRILOCAINE HYPERBAR SINTETICA in esclusiva per l'Italia
28/10/2008
A partire dal 01 novembre 2008 Unipharma SA distribuirà in esclusiva in Italia il prodotto:
PRILOCAINE HYPERBAR SINTETICA 2% 10 fiale 5 ml
Adresse
IMPORT EXPORT DIVISION
Tel. +41 (0)91 985 62 11Fax. +41 (0)91 985 62 22
Kunden: sales@unipharma.ch
Lieferanten: purchase@unipharma.ch
SITZ
Unipharma SA Via Pian ScairoloCH - 6917 Barbengo, Lugano
Tel. +41 (0)91 985 62 11
Fax. +41 (0)91 985 62 22
General: unipharma@unipharma.ch